These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20399488)

  • 1. Long-term treatment of renal lithiasis with potassium citrate.
    Spivacow FR; Negri AL; Polonsky A; Del Valle EE
    Urology; 2010 Dec; 76(6):1346-9. PubMed ID: 20399488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium citrate decreases urine calcium excretion in patients with hypocitraturic calcium oxalate nephrolithiasis.
    Song Y; Hernandez N; Shoag J; Goldfarb DS; Eisner BH
    Urolithiasis; 2016 Apr; 44(2):145-8. PubMed ID: 26582172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation.
    Koff SG; Paquette EL; Cullen J; Gancarczyk KK; Tucciarone PR; Schenkman NS
    Urology; 2007 Jun; 69(6):1013-6. PubMed ID: 17572176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Citrate and renal stones].
    del Valle EE; Spivacow FR; Negri AL
    Medicina (B Aires); 2013; 73(4):363-8. PubMed ID: 23924538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypocitraturia despite potassium citrate tablet supplementation.
    Shenoy C
    MedGenMed; 2006 Jul; 8(3):8. PubMed ID: 17406150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypocitraturia: a common but not well-known cause of nephrolithiasis.
    Bos S; Nap RR; Wouters RS; van der Kleij FG
    Neth J Med; 2014 Dec; 72(10):545-7. PubMed ID: 26219761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of potassium citrate delayed preparation in urine PH and citric acid content].
    He HC; Zhong WD; Xie KJ; Dai QS; Zeng GQ; Wei H; Wei HA; Mei H
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1825-6. PubMed ID: 15631783
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term lemonade based dietary manipulation in patients with hypocitraturic nephrolithiasis.
    Kang DE; Sur RL; Haleblian GE; Fitzsimons NJ; Borawski KM; Preminger GM
    J Urol; 2007 Apr; 177(4):1358-62; discussion 1362; quiz 1591. PubMed ID: 17382731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of long-term potassium citrate therapy on urinary profiles and recurrent stone formation.
    Robinson MR; Leitao VA; Haleblian GE; Scales CD; Chandrashekar A; Pierre SA; Preminger GM
    J Urol; 2009 Mar; 181(3):1145-50. PubMed ID: 19152932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Response in Patients with Stones, and Low Urinary pH and Hypocitraturia Stratified by Body Mass Index.
    Astroza GM; Neisius A; Tsivian M; Preminger GM; Lipkin ME
    J Urol; 2016 Mar; 195(3):653-7. PubMed ID: 26393903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetazolamide is an effective adjunct for urinary alkalization in patients with uric acid and cystine stone formation recalcitrant to potassium citrate.
    Sterrett SP; Penniston KL; Wolf JS; Nakada SY
    Urology; 2008 Aug; 72(2):278-81. PubMed ID: 18533229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronopharmacological studies on potassium citrate treatment of oxalocalcic urolithiasis.
    Grases F; Conte A; March JG; García-Ferragut L; Villalonga N
    Int Urol Nephrol; 1997; 29(3):263-73. PubMed ID: 9285296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
    Sakhaee K; Poindexter JR; Griffith CS; Pak CY
    J Urol; 2004 Sep; 172(3):958-61. PubMed ID: 15311008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The optimal dose of potassium citrate in the treatment of children with distal renal tubular acidosis.
    Tapaneya-Olarn W; Khositseth S; Tapaneya-Olarn C; Teerakarnjana N; Chaichanajarernkul U; Stitchantrakul W; Petchthong T
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1143-9. PubMed ID: 12549788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of spinal bone loss by potassium citrate in cases of calcium urolithiasis.
    Pak CY; Peterson RD; Poindexter J
    J Urol; 2002 Jul; 168(1):31-4. PubMed ID: 12050486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cost-effectiveness analysis of preventive treatment of urinary lithiasis recurrence using potassium citrate].
    Gisbert Gelonch R; Fernández Augusto L
    Arch Esp Urol; 1997 May; 50(4):373-80. PubMed ID: 9313046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of potassium citrate in the prophylaxis of urinary lithiasis].
    Jiménez Verdejo A; Arrabal Martín M; Miján Ortiz JL; Hita Rosino E; Palao Yago F; Zuluaga Gómez A
    Arch Esp Urol; 2001 Nov; 54(9):1036-46. PubMed ID: 11789361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium dicarboxylate cotransporter-1 expression in renal tissues and its role in rat experimental nephrolithiasis.
    He Y; Chen X; Yu Z; Wu D; Lv Y; Shi S; Zhu H
    J Nephrol; 2004; 17(1):34-42. PubMed ID: 15151257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of potassium-magnesium citrate supplementation on cytosolic ATP citrate lyase and mitochondrial aconitase activity in leukocytes: a window on renal citrate metabolism.
    Tosukhowong P; Tungsanga K; Phongudom S; Sriboonlue P
    Int J Urol; 2005 Feb; 12(2):140-4. PubMed ID: 15733107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.